LATEST ALERTS
Regulation and legislation
German ministry punished for delay over cannabis legislation by €1m funding cut
12th January 2023 - News analysis |
The German Ministry of Health’s budget has been slashed by €1m in a bid to put pressure on health minister Karl Lauterbach to present a draft law for the legalisation of cannabis
Much-needed research into SCRAs’ huge medical potential faces high barriers
12th January 2023 - Blogs |
The recreational reputation of synthetic cannabinoids – synthetic cannabinoid receptor agonists (SCRAs) – precedes them, leading to restrictions on use and even research
Importing and exporting of hemp and CBD in the EU
11th January 2023 - Regulatory reports |
This report provides an overview of the applicable framework for the movement of hemp and CBD within the borders of the EU as well as the import and export to and from “third countries”
Google changes policy to allow advertising of certain CBD products…
9th January 2023 - Alerts | North America, United States |
Senate passes bill to legalise recreational cannabis…
9th January 2023 - Alerts | North America, United States, Virgin Islands |
FDA to make regulation recommendations for CBD…
9th January 2023 - Alerts | North America, United States |
Recreational sales began on 29th December…
9th January 2023 - Alerts | New York, North America, United States |
Japan cannabinoid conference-goers look forward to future with legal reforms
9th January 2023 - News analysis |
There are high hopes for the Japanese cannabinoid sector ahead of the legal reforms expected later this year, according to speakers at the CBD Journey Vol. 4 and CannaCon 2022 event and conference held at the end of 2022
Monaco: CBD and cannabis regulation, January 2023
9th January 2023 - Regulatory reports |
This report provides a detailed summary of the current regulations in place for hemp, cannabis and CBD in Monaco, covering all areas from cultivation and processing to extracts and finished products
Colombia ready to lead Latin America into a more cannabis-friendly future
5th January 2023 - News analysis |
CannIntelligence reviews developments in cannabis regulation in Latin America in 2022 and looks forward to likely further opening-up of the industry in many of the region’s nations in 2023
Australia: CBD and cannabis regulation, January 2023
4th January 2023 - Regulatory reports |
This report provides a detailed overview of Australia’s federal and state regulation of hemp, CBD and cannabis, covering everything from cultivation to extracts and finished products, as well as the medical and recreational cannabis regimes
Is 2023 the year for the great leap forward on cannabis regulation?
3rd January 2023 - News analysis |
Will 2023 be the year that some fairly major changes start to roll in for cannabis and cannabinoids? It’s possible
An overview of intoxicating hemp-derived cannabinoids in Europe
2nd January 2023 - Regulatory reports |
This report examines the basic regulatory framework for the most popular IHDC product categories and identifies the IHDC product that is most likely to be allowed in Europe
US FDA again issues warning letters on CBD in ingestibles, this time with a twist
30th December 2022 - News analysis |
The FDA has made clear for years that CBD in food is illegal in the US, as it violates the Federal Food, Drug, and Cosmetic (FD&C) Act. What’s different this time?
A watershed year? 2022 sees cannabis on the rise, while CBD goes downhill
30th December 2022 - News analysis |
This past year has seen a curious crossing of paths in the world of cannabis and cannabinoids, with concerns around CBD increasing even as many countries make moves towards the legalisation of cannabis
The question of semi-synthetics – HHC comes under scrutiny by EU authorities
29th December 2022 - News analysis |
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has begun the process of collecting data and evaluating the risk posed by hexahydrocannabinol (HHC) and other semi-synthetic cannabinoids
Two US cannabis companies fight out contract dispute in California courts
23rd December 2022 - News analysis |
A 2021 acquisition deal between two cannabis companies over a lucrative shopfront in Orange County, California, has resulted in both companies filing legal claims against each other
A workaround for access to medical cannabis…
21st December 2022 - Alerts | District of Columbia, North America, United States |
As legal cannabinoid markets spread, UN considers vexed question of regulation
20th December 2022 - News analysis |
The United Nations may be growing more accepting of a global legal cannabinoid sector, but it does not believe many countries have the capacity to successfully regulate such markets
Health department to issue new licences for medical cannabis centres…
20th December 2022 - Alerts | Florida, North America, United States |
SAFE Banking Act on shaky ground with new Congress?
20th December 2022 - Alerts | North America, United States |
Hong Kong to ban CBD in the new year, ending a once-burgeoning business
19th December 2022 - News analysis |
The sale and possession of CBD will be banned in Hong Kong from the beginning of February 2023 following an announcement earlier this year. Under the new rules, CBD will be classified in the same way as heroin and cocaine
Minister responds to ACMD research on subject of research barriers…
19th December 2022 - Alerts | Europe, United Kingdom |
Government publishes Q&A on cooperatives and cannabis…
19th December 2022 - Alerts | Argentina, South America |
Anvisa authorises cannabis cultivation for research purposes…
19th December 2022 - Alerts | Brazil, South America |
Anxiety disorder now a qualifying condition for medical cannabis prescriptions…
19th December 2022 - Alerts | New Mexico, North America, United States |
Italy: CBD and cannabis regulation, December 2022
19th December 2022 - Regulatory reports |
This report provides a detailed overview of the current regulatory framework in place for CBD, hemp and cannabis, covering all policy areas
Advocates for psylocibin as therapeutic treatment push Canadian government
16th December 2022 - News analysis |
Canadian advocates for therapeutic access to psilocybin are ramping up their efforts to get the federal government to grant exemptions to the country’s drug laws so patients and healthcare providers can legally access the drug
Executives acquitted of fraud relating to cannabis production…
16th December 2022 - Alerts | Canada, North America |
Germany: CBD and cannabis snapshot
15th December 2022 - Market reports , Regulatory reports |
This snapshot of Germany’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Spain: CBD and cannabis snapshot
14th December 2022 - Market reports , Regulatory reports |
This snapshot of Spain’s CBD and cannabis sector covers both the regulatory framework for CBD as well as cannabis (recreational and medical) and offers an overview of the market, online retailers and consumer preferences
Guidance issued on cannabis delivery…
12th December 2022 - Alerts | New York, North America, United States |
First legal recreational cannabis sales to begin in January…
12th December 2022 - Alerts | Connecticut, North America, United States |
Basel to begin recreational cannabis sales in January…
9th December 2022 - Alerts | Europe, Switzerland |
New US cannabis research law – ‘historic breakthrough’ or merely ‘a baby step’?
7th December 2022 - News analysis |
The Medical Marijuana and Cannabidiol Research Expansion Act, aimed at increasing research into the medical benefits of cannabis, has been signed into law by US president Joe Biden
